Literature DB >> 16242266

Antibacterial and cytotoxic compounds from the bark of Cananga odorata.

M Mukhlesur Rahman1, Simin S Lopa, Golam Sadik, Robiul Islam, Proma Khondkar, A H M Khurshid Alam, Mohammad A Rashid.   

Abstract

O-Methylmoschatoline, liriodenine and 3,4-dihydroxybenzoic acid isolated from the barks of Cananga odorata showed antibacterial activities against a number of Gram (+) and Gram (-) bacteria. The compounds also showed antifungal and cytotoxic activities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16242266     DOI: 10.1016/j.fitote.2005.08.011

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  5 in total

1.  The medicinal plants of Myanmar.

Authors:  Robert A DeFilipps; Gary A Krupnick
Journal:  PhytoKeys       Date:  2018-06-28       Impact factor: 1.635

Review 2.  Traditional Uses, Phytochemistry, and Bioactivities of Cananga odorata (Ylang-Ylang).

Authors:  Loh Teng Hern Tan; Learn Han Lee; Wai Fong Yin; Chim Kei Chan; Habsah Abdul Kadir; Kok Gan Chan; Bey Hing Goh
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-30       Impact factor: 2.629

3.  Liriodenine, an aporphine alkaloid from Enicosanthellum pulchrum, inhibits proliferation of human ovarian cancer cells through induction of apoptosis via the mitochondrial signaling pathway and blocking cell cycle progression.

Authors:  Noraziah Nordin; Nazia Abdul Majid; Najihah Mohd Hashim; Mashitoh Abd Rahman; Zalila Hassan; Hapipah Mohd Ali
Journal:  Drug Des Devel Ther       Date:  2015-03-10       Impact factor: 4.162

Review 4.  Anti-Infective and Anti-Cancer Properties of the Annona Species: Their Ethnomedicinal Uses, Alkaloid Diversity, and Pharmacological Activities.

Authors:  Ari Satia Nugraha; Yuvita Dian Damayanti; Phurpa Wangchuk; Paul A Keller
Journal:  Molecules       Date:  2019-12-03       Impact factor: 4.411

Review 5.  Annonaceae: Breaking the Wall of Inflammation.

Authors:  Ali Attiq; Juriyati Jalil; Khairana Husain
Journal:  Front Pharmacol       Date:  2017-10-20       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.